Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Acquisition

1 Apr 2009 07:00

RNS Number : 8894P
First Derivatives PLC
01 April 2009
 



1 April 2009

First Derivatives plc

(AIM:FDP.L, IEX:GYQ.I)

Acquisition of Hologram

The Board of First Derivatives plc ("First Derivatives" or the "Company") announces that it has acquired Lepton Solutions Pty Limited (trading as "Hologram"), an Australian based technology company headquartered in Adelaide, for a total cash consideration of up to 2.2 million Australian dollars and 400,000 share options (the "Acquisition").  The Acquisition comprises an initial cash payment of 1.0 million Australian dollars.  In addition the four principals who own 96.4% of Hologram will receive 400,000 share options in First Derivatives (representing 2.9% of the Company's issued share capital). The share options vesting is subject to Hologram and its four principals achieving certain sales targets during the three years ending 31 March 2012. An additional deferred consideration to the four principals of Hologram, is payable, of up to a maximum of 1.2 million Australian dollars in cash.

Founded in 2004, with offices in Sydney and Adelaide, Hologram principals are leaders in the field of Risk Management and Stock Exchange Trading software. Risk management software developed by them was bought by Sungard and is in use in several hundred financial institutions and corporate treasuries worldwide. Their stock exchange trading system which is also currently in use in many stock exchanges around the world was sold to Computershare and is now owned by NASDAQ. In addition Hologram is the exclusive Australasian partner of Kx Systems in the financial services sector which complements First Derivatives exclusive partnership with Kx Systems in the financial services sector for North America, UK and Ireland.

The Acquisition grows First Derivatives existing presence in Asia Pacific and will help accelerate the Company's expansion by enhancing its global service offering. Hologram will also provide another channel to market for the Company's Delta product range for the Financial Services Sector in the areas of Algorithmic Trading, Market Data, Complex Event Processing (CEP) and Risk Management.

First Derivatives' CEO Brian Conlon said "The skills of Hologram's executive team complement those of First Derivatives extremely well and Hologram's product range will slot seamlessly into our Delta product suite. The Hologram principals have a track record of developing and marketing enterprise software in our domain and this expertise adds to our team of world class technology professionals. We continue to invest significant resources in research and development and the acquisition will help us expand our range of applications and adds corporate treasuries to our target customer base. The transaction is a coming together of two very like minded firms with a mutual emphasis on professionalism and a drive to produce market leading software."

Paul Phillips from Hologram said "We are excited about the opportunities that this transaction provides for Hologram. It gives us additional channels to market for our Treasury and Enterprise Risk Management systems and allows us to accelerate our plans by leveraging First Derivatives global presence and expertise in Kx technology. In addition we are looking forward to growing First Derivatives' sales and consulting presence in the Asia Pacific region and the acquisition will also enable us to expand our European operations in our Treasury Risk Consulting Business. 

Contact:

First Derivatives plc

Brian Conlon

 

Tel: +44 (0)28 3025 2242

Charles Stanley Securities

Nominated Adviser

Russell Cook/Carl Holmes

 

Tel: +44 (0)20 7149 6000

Goodbody Corporate Finance 

IEX Adviser

Diane Hodgson/Linda Hickey

 

Tel: +353 1 667 0420

Stakeholder Communications 

Carl Whyte 

Lisa Nugent

Tel: +44 (0)28 9033 9949

Tel: +44 (0) 20 7903 5148

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUUUUACUPBUAG
Date   Source Headline
17th Aug 20074:59 pmRNSDisclosure of Information
3rd Aug 200712:01 pmRNSExercise of options
27th Jul 20073:11 pmRNSTotal Voting Rights
6th Jul 200712:41 pmRNSExercise of Options
8th Jun 20077:00 amRNSIEX Notice
7th Jun 20072:08 pmRNSResult of AGM
6th Jun 20075:27 pmRNSIEX Schedule One Update
21st May 200710:32 amRNSDirector/PDMR Shareholding
18th May 200710:21 amRNSFinal Results - REPLACEMENT
10th May 200710:48 amRNSIEX Schedule One
10th May 20077:01 amRNSFinal Results
3rd Apr 20079:29 amRNSTotal Voting Rights
6th Mar 20071:25 pmRNSExercise of Options
28th Feb 20073:14 pmRNSTotal Voting Rights
27th Feb 20072:07 pmRNSIssue of Equity
8th Feb 20077:00 amRNSTrading Statement
31st Jan 20071:55 pmRNSTotal Voting Rights
30th Jan 20077:01 amRNSExercise of Options
12th Jan 20075:24 pmRNSDirector/PDMR Shareholding
11th Jan 20074:59 pmRNSDirector/PDMR Shareholding
20th Dec 20064:29 pmRNSTotal Voting Rights
20th Dec 20064:20 pmRNSIssue of Equity
19th Oct 20063:41 pmRNSDirector/PDMR Shareholding
5th Oct 20068:52 amRNSExercise of Options
26th Sep 20067:01 amRNSInterim Results
1st Jun 200612:05 pmRNSResult of AGM
22nd May 20063:09 pmRNSDirector/PDMR Shareholding
9th May 20065:53 pmRNSDividend Update Statement
9th May 20067:01 amRNSFinal Results
24th Apr 20062:50 pmRNSNotice of Results
17th Mar 20067:02 amRNSTrading Statement
10th Mar 20062:49 pmRNSExercise of Options
10th Mar 20062:38 pmRNSDirector/PDMR Shareholding
24th Nov 20057:01 amRNSDirectorate Change
7th Oct 20053:24 pmRNSDirector/PDMR Shareholding
22nd Sep 20057:00 amRNSInterim Results
28th Jun 20055:26 pmRNSResult of AGM
27th May 20052:37 pmRNSDividend Declaration
25th May 20057:01 amRNSFinal Results
3rd May 20057:00 amRNSTrading update
9th Feb 20052:32 pmRNSNew Contract Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.